奥锐特 (605116)
Aurisco Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 40619.52
- Circulating A-Shares(W): 40618.32
- Earnings Per Share(RMB): 0.8700
- Net Assets Per Share(RMB): 6.2093
- Operating Revenue(W RMB): 123705.26
- Total Profit(W RMB): 40407.66
- **Net Profit Attributable to Parent(W RMB) **: 35354.06
- Net Profit Growth Rate(%): 24.58
- Weighted Return on Equity(%): 14.3700
- Operating Cash Flow Per Share(RMB): 0.8650
- Undistributed Profit Per Share(RMB): 3.3456
- Capital Reserve Per Share(RMB): 1.5107
2. Main Business
The main business covers:
- Research, development, production and sales of specialty APIs and pharmaceutical intermediates
3. Company Basic Information
- Company Name: Aurisco Pharmaceutical Co., Ltd.
- Listing Date: 2020-09-21
- Industry: Pharmaceutical Manufacturing
- Address: Badu Industrial Park, Tiantai County, Zhejiang Province
- Website: https://www.aurisco.com/
- Company Profile: On May 16, 2017, according to the resolution of Aurisco Limited's shareholders' meeting, Aurisco Limited was converted into a joint stock company through overall change, using the audited net assets of RMB 601,764,333.25 after deducting the safety production reserve as of March 31, 2017. RMB 360,000,000.00 was converted into share capital, and the remaining RMB 241,764,333.25 was recorded as capital reserve. On June 1, 2017, Tianjian Certified Public Accountants verified the receipt of registered capital during this overall change and establishment, and issued the "Capital Verification Report" (Tianjian Yan [2017] No. 207). On June 29, 2017, the company completed the industrial and commercial change registration procedures and obtained the business license issued by the Taizhou Market Supervision Administration.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Zhejiang Tongben Investment Co., Ltd. | Corporate Entity | 15358.32 | 38.00 |
| 2 | Tiantai Borong Investment Partnership (Limited Partnership) | Corporate Entity | 773.06 | 1.91 |
| 3 | Tiantai Boen Investment Management Partnership (Limited Partnership) | Corporate Entity | 660.60 | 1.63 |
| 4 | Guoshou Anbao Health Science Hybrid Securities Investment Fund Class A | Fund | 21.00 | 0.05 |
5. Concept Sectors
- Convertible Bonds
- Quantum Technology
- Generic Drugs
- CXO Concept
- Assisted Reproduction
- Hepatitis Concept
- Innovative Drugs
- Weight Loss Drugs
- Synthetic Biology
- High-Performing Stocks
- Share Buyback Plan
- Proposed Reduction
- Overseas Business
Remarks
- Data update date: 2025-11-07
- Data source: Public Market Information